Table 1.
Model | m/z | Lipid | Configuration | Ion |
---|---|---|---|---|
Cancer vs Normal | 673.481 | Phosphatidic acid | PA(34:1) | [M − H]− |
699.497 | Phosphatidic acid/Phosphatidyl-ethanolamine | PA(36:2 / PE(34:1) | [M − H]–/[M − NH3]− | |
744.555 | Phosphatidyl-ethanolamine | PE(36:1) | [M − H]− | |
Cancer vs BOT | 699.497 | Phosphatidic acid/Phosphatidyl-ethanolamine | PA(36:2 / PE(34:1) | [M − H]−/[M − NH3]− |
742.539 | Phosphatidyl-ethanolamine | PE(36:2) | [M – H]− | |
685.517 | Phosphatidic-acid-plasmalogen | PA(P-36:1) | [M − H]− |
Tandem MS and LipidMAPS used along with locally derived lipid data sets from previous REIMS work to tentatively assign lipid classifications and configurations. PA phosphatidic acid, PE phosphatidyl-ethanolamine